Kering SA (EPA:PRTP), the luxury group behind Gucci, has agreed to sell its beauty business to L’Oréal SA (EPA:OREP) for €4 billion ($4.66 billion) as part of its strategic shift to strengthen its core fashion operations. The deal, announced on Sunday, marks a major step in Kering’s ongoing efforts to reduce debt and regain financial stability under the leadership of new CEO Luca de Meo.
As part of the agreement, Kering will divest its House of Creed unit to L’Oréal, transferring ownership of the high-end fragrance brand. In addition, L’Oréal will secure 50-year exclusive licenses to develop and distribute fragrances and beauty products for Kering’s prestigious fashion houses—Gucci, Bottega Veneta, and Balenciaga. Both companies have also expressed interest in pursuing future collaborative opportunities to expand their partnership in the global luxury beauty sector.
The sale is seen as a decisive move by Kering to streamline its portfolio and focus on revitalizing its flagship fashion labels, particularly Gucci, which has struggled amid slowing luxury demand in major markets like China. Analysts note that the divestment could help the company significantly reduce its net debt, which has been a growing concern among investors in recent months.
For L’Oréal, the acquisition strengthens its dominance in the luxury fragrance market, adding Kering’s coveted brands to its extensive beauty portfolio. The deal highlights the growing trend of consolidation within the luxury sector as major players aim to adapt to shifting consumer behavior and global economic pressures.
With this transaction, Kering positions itself to rebuild profitability and brand strength, while L’Oréal continues to expand its leadership in premium beauty—a win-win for both French powerhouses.


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Apple Turns 50: From Garage Startup to AI Crossroads
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 



